1-4 of 4
Zita Borbenyi, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Panobinostat Plus Azacitidine in Adult Patients with MDS, CMML, or AML: Results of a Phase 2b Study

Guillermo Garcia-Manero, MD, Mikkael A. Sekeres, MD MS, Miklos Egyed, MDPhD Prof., Giuliana Alimena, MD, Carlos Graux, Jamie D. Cavenagh, MD, Huda Salman, Arpad Illes, MD PhD, Pierre Fenaux, MD PhD, Daniel J. DeAngelo, Reinhard Stauder, MD MSc, Karen Yee, MD, Nancy Y Zhu, MDFRCPC, Je-Hwan Lee, MD PhD, David Valcarcel, MD PhD, Alan MacWhannell, Zita Borbenyi, MD PhD, Antje Wegener, Lucien Gazi, Suddhasatta Acharyya, PhD, Florence Binlich, Oliver G. Ottmann, MD
Journal: Blood
Blood (2015) 126 (23): 2861.
https://doi.org/10.1182/blood.V126.23.2861.2861
Published: 2015
Journal Articles

Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice

Mohamad Mohty, MD PhD, Evangelos Terpos, Maria-Victoria Mateos, Antonio Palumbo, MD, Sandra Lejniece, Meral Beksac, MD, Mohamed Amine Bekadja, Wojciech Legiec, Meletios Dimopoulos, Svetlana Stankovic, PhD, Maria Soledad Durán, Valerio De Stefano, MD, Alessandro Corso, MD, Yulia Kochkareva, Edward Laane, MD PhD, Christian Berthou, MD PhD, Hans-Juergen Salwender, MD, Zvenyslava Masliak, Valdas Pečeliūnas, Wolfgang Willenbacher, MD, João Da Silva, Vernon Louw, Damir Nemet, MD PhD, Zita Borbényi, MD PhD, Uri Abadi, MD, Robert Schou Pedersen, Peter Cernelc, Anna Potamianou, MD PhD, Catherine Couturier, Robert Olie, PhD, Caroline Feys, MSc, MBA, Florence Thoret-Bauchet, Mario Boccadoro, MD
Journal: Blood
Blood (2015) 126 (23): 3034.
https://doi.org/10.1182/blood.V126.23.3034.3034
Published: 2015
Journal Articles

Immunochemotherapy As Induction (R-CHOP and R-HyperC-VAD/R-MA) in Mantle Cell Lymphoma, a Hungarian Multicenter Open Label Phase II Study (Rituximab [MabThera®] in Mantle Cell Lymphoma, REMENY)

Miklos Udvardy, MD, PhD, Andras Rosta, MD, PhD, Zoltan Gasztonyi, MD, Zita Borbenyi, MD, PhD, Gaspar Radvanyi, MD, Miklos Egyed, MD, PhD, Beata Gasztonyi, MD, PhD, Hajna Losonczy, MD, PhD, Andras Matolcsy, MD, PhD, Agnes H. Andrasfalvy, MD, Tamas J. Schneider, MD
Journal: Blood
Blood (2012) 120 (21): 4889.
https://doi.org/10.1182/blood.V120.21.4889.4889
Published: 2012
Journal Articles

Results of the Interim Analysis of the “HUSOM” Trial: Hungarian Study of Maintenance After Rituximab Pretreatment, A Multicentre, Phase III, Open-Label Study Evaluating the Benefit of a Long-Term MabThera (rituximab) Maintenance Therapy in Patients with Advance Follicular Lymphoma After Induction of Response (CR(u) or PR) with a MabThera (rituximab)-Containing First Line Regimen

Tamas J. Schneider, MD, Andras Rosta, MD, PhD, Hajna Losonczy, MD, PhD, Gaspar Radvanyi, MD, Gyorgy Ujj, MD, Arpad Illes, MD, PhD, János Jakucs, MD, Zita Borbenyi, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2714.
https://doi.org/10.1182/blood.V118.21.2714.2714
Published: 2011